Literature DB >> 21484373

Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743.

Winnie Deuther-Conrad1, Steffen Fischer, Achim Hiller, Georg Becker, Paul Cumming, Guoming Xiong, Uta Funke, Osama Sabri, Dan Peters, Peter Brust.   

Abstract

PURPOSE: To conduct a quantitative PET assessment of the specific binding sites in the brain of juvenile pigs for [(18)F]NS10743, a novel diazabicyclononane derivative targeting α7 nicotinic acetylcholine receptors (α7 nAChRs).
METHODS: Dynamic PET recordings were made in isoflurane-anaesthetized juvenile pigs during 120 min after administration of [(18)F]NS10743 under baseline conditions (n = 3) and after blocking of the α7 nAChR with NS6740 (3 mg·kg(-1) bolus + 1 mg·kg(-1)·h(-1) continuous infusion; n = 3). Arterial plasma samples were collected for determining the input function of the unmetabolized tracer. Kinetic analysis of regional brain time-radioactivity curves was performed, and parametric maps were calculated relative to arterial input.
RESULTS: Plasma [(18)F]NS10743 passed readily into the brain, with peak uptake occurring in α7 nAChR-expressing brain regions such as the colliculi, thalamus, temporal lobe and hippocampus. The highest SUV(max) was approximately 2.3, whereas the lowest uptake was in the olfactory bulb (SUV(max) 1.53 ± 0.32). Administration of NS6740 significantly decreased [(18)F]NS10743 binding late in the emission recording throughout the brain, except in the olfactory bulb, which was therefore chosen as reference region for calculation of BP(ND). The baseline BP(ND) ranged from 0.39 ± 0.08 in the cerebellum to 0.76 ± 0.07 in the temporal lobe. Pretreatment and constant infusion with NS6740 significantly reduced the BP(ND) in regions with high [(18)F]NS10743 binding (temporal lobe -29%, p = 0.01; midbrain: -35%, p = 0.02), without significantly altering the BP(ND) in low binding regions (cerebellum: -16%, p = 0.2).
CONCLUSION: This study confirms the potential of [(18)F]NS10743 as a target-specific radiotracer for the molecular imaging of central α7 nAChRs by PET.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484373     DOI: 10.1007/s00259-011-1808-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  34 in total

1.  Kinetics of the metabolism of four PET radioligands in living minipigs.

Authors:  N M Gillings; D Bender; L Falborg; K Marthi; O L Munk; P Cumming
Journal:  Nucl Med Biol       Date:  2001-01       Impact factor: 2.408

2.  Traumatic brain injury elicits similar alterations in α7 nicotinic receptor density in two different experimental models.

Authors:  Peter-Georg Hoffmeister; Cornelius K Donat; Martin U Schuhmann; Cornelia Voigt; Bernd Walter; Karen Nieber; Jürgen Meixensberger; Reinhard Bauer; Peter Brust
Journal:  Neuromolecular Med       Date:  2010-09-21       Impact factor: 3.843

Review 3.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

4.  Pig brain stereotaxic standard space: mapping of cerebral blood flow normative values and effect of MPTP-lesioning.

Authors:  Flemming Andersen; Hideaki Watanabe; Carsten Bjarkam; Erik H Danielsen; Paul Cumming
Journal:  Brain Res Bull       Date:  2005-04-26       Impact factor: 4.077

5.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

6.  Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.

Authors:  A R Davies; D J Hardick; I S Blagbrough; B V Potter; A J Wolstenholme; S Wonnacott
Journal:  Neuropharmacology       Date:  1999-05       Impact factor: 5.250

Review 7.  Neuronal nicotinic receptors: from structure to pathology.

Authors:  C Gotti; F Clementi
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

8.  Alpha7 neuronal nicotinic receptors: the missing link to understanding Alzheimer's etiopathology?

Authors:  Merouane Bencherif; Patrick M Lippiello
Journal:  Med Hypotheses       Date:  2009-10-01       Impact factor: 1.538

9.  Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.

Authors:  L Maggi; E Palma; F Eusebi; M Moretti; B Balestra; F Clementi; C Gotti
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

10.  Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1.

Authors:  Shiny V Mathew; Amanda J Law; Barbara K Lipska; Martha I Dávila-García; Eduardo D Zamora; Shruti N Mitkus; Radhakrishna Vakkalanka; Richard E Straub; Daniel R Weinberger; Joel E Kleinman; Thomas M Hyde
Journal:  Hum Mol Genet       Date:  2007-09-20       Impact factor: 6.150

View more
  12 in total

1.  Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.

Authors:  Andrew G Horti; Hayden T Ravert; Yongjun Gao; Daniel P Holt; William H Bunnelle; Michael R Schrimpf; Tao Li; Jianguo Ji; Heather Valentine; Ursula Scheffel; Hiroto Kuwabara; Dean F Wong; Robert F Dannals
Journal:  Nucl Med Biol       Date:  2013-01-05       Impact factor: 2.408

Review 2.  Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography.

Authors:  Peter Brust; Jörg van den Hoff; Jörg Steinbach
Journal:  Neurosci Bull       Date:  2014-08-29       Impact factor: 5.203

3.  Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy.

Authors:  Dean F Wong; Hiroto Kuwabara; Martin Pomper; Daniel P Holt; James R Brasic; Noble George; Boris Frolov; William Willis; Yongjun Gao; Heather Valentine; Ayon Nandi; Lorena Gapasin; Robert F Dannals; Andrew G Horti
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

4.  Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.

Authors:  Yongjun Gao; Kenneth J Kellar; Robert P Yasuda; Thao Tran; Yingxian Xiao; Robert F Dannals; Andrew G Horti
Journal:  J Med Chem       Date:  2013-09-19       Impact factor: 7.446

5.  5-(5-(6-[(11)C]methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)pyridin-2-yl)-1H-indole as a potential PET radioligand for imaging cerebral α7-nAChR in mice.

Authors:  Yongjun Gao; Hayden T Ravert; Heather Valentine; Ursula Scheffel; Paige Finley; Dean F Wong; Robert F Dannals; Andrew G Horti
Journal:  Bioorg Med Chem       Date:  2012-05-04       Impact factor: 3.641

6.  PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans.

Authors:  Ansel T Hillmer; Songye Li; Ming-Qiang Zheng; Matthias Scheunemann; Shu-Fei Lin; Nabeel Nabulsi; Daniel Holden; Richard Pracitto; David Labaree; Jim Ropchan; Rodrigo Teodoro; Winnie Deuther-Conrad; Irina Esterlis; Kelly P Cosgrove; Peter Brust; Richard E Carson; Yiyun Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-24       Impact factor: 9.236

Review 7.  Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors.

Authors:  Alina Kassenbrock; Neil Vasdev; Steven H Liang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 8.  Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.

Authors:  Andrew G Horti
Journal:  Biochem Pharmacol       Date:  2015-07-29       Impact factor: 5.858

Review 9.  PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis.

Authors:  Matthias Bauwens; Felix M Mottaghy; Jan Bucerius
Journal:  Curr Cardiol Rep       Date:  2015-08       Impact factor: 2.931

10.  Imaging of α7 nicotinic acetylcholine receptors in brain and cerebral vasculature of juvenile pigs with [(18)F]NS14490.

Authors:  Sven Rötering; Winnie Deuther-Conrad; Paul Cumming; Cornelius K Donat; Matthias Scheunemann; Steffen Fischer; Guoming Xiong; Jörg Steinbach; Dan Peters; Osama Sabri; Jan Bucerius; Peter Brust
Journal:  EJNMMI Res       Date:  2014-08-05       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.